EDGAR Filing Documents for 0000898432-07-000847

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000898432-07-000847

Filing Date

2007-09-27

Accepted

2007-09-27 15:00:33

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.INVESTMENTS 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		sc-13g.htm	SC 13G	94667
2	EXHIBIT 1	exhibit_99.htm	EX-99	12947
	Complete submission text file	0000898432-07-000847.txt		109727

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142

Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-914-3400

VIACELL INC (Subject) CIK: 0001114529 (see all company filings)

IRS No.: 043244816
Type: SC 13G | Act: 34 | File No.: 005-81150 | Film No.: 071139128
SIC: 8731 Services-Commercial Physical & Biological Research